Elevance Health, US0367521038

Elevance Health stock: Mizuho keeps Buy rating, sets USD 490 target

Published on 11/17/2026 at 16:17 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Elevance Health stock remains in focus after Mizuho reaffirmed its Buy view. The latest quarter provides the backdrop for the analyst's assessment.

Mizuho Keeps Buy View

  • Mizuho maintained its Buy rating as Elevance Health's recovery prospects remained in focus.
  • The latest quarterly release showed higher revenue and net profit than a year earlier.
  • Medical-cost trends and enrollment remain important factors for the insurer's outlook.
Elevance Health, US0367521038, Illustration mit AI erstellt.

Mizuho Securities maintained a Buy rating on Elevance Health and set a USD 490 price target, according to a Markets Insider report published on November 16, 2026. The analyst action keeps attention on the insurer's margin recovery and the assumptions supporting its earnings path.

Mizuho Keeps Buy View

Analyst Ann Hynes maintained the Buy rating rather than changing the recommendation. The USD 490 target applies to Elevance Health's New York-listed shares and represents an external valuation view, not company guidance.

Quarterly Results Set Context

Markets Insider linked the analyst view to Elevance Health's latest earnings release for the quarter ended September 30. Revenue was USD 51.43 billion, compared with USD 50.71 billion a year earlier, while net profit reached USD 1.37 billion versus USD 1.19 billion.

For investors, the rating leaves execution against the insurer's earnings outlook as the central operating question. Medical-cost development and enrollment trends remain relevant to the quality of any margin recovery.

Elevance Health stock traded at 398.60 euros on Lang & Schwarz at 16:07 CET on Tuesday, November 17, 2026.

Elevance Health at a Glance

  • Company: Elevance Health
  • ISIN: US0367521038
  • Trading venue: Lang & Schwarz
  • Quoted price: EUR 398.60 at 16:07 CET on November 17, 2026

US healthcare stocks remain part of the broader market focus. See Current market reports for the latest market coverage.

More news and analyses on Elevance Health stock.

Disclaimer...
en | US0367521038 | ELEVANCE HEALTH | boerse | 70527552 | bgmi